IMI - Intermolecular, Inc.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue47,29845,32247,695
Cost of Revenue15,83019,30424,651
Gross Profit31,46826,01823,044
Operating Expenses
Research Development28,12628,57624,320
Selling General and Administrative18,09618,16818,406
Non Recurring1,1141,1141,361
Total Operating Expenses---
Operating Income or Loss-15,868-20,726-21,043
Income from Continuing Operations
Total Other Income/Expenses Net265-12-29
Earnings Before Interest and Taxes-15,430-21,005-21,754
Interest Expense---
Income Before Tax-15,430-21,005-21,754
Income Tax Expense787
Minority Interest---
Net Income From Continuing Ops-15,437-21,013-21,761
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-15,437-21,013-21,761
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-15,437-21,013-21,761